The criteria for identification of Enterococcus faecium (Efm) with the ability to cause human infections are currently being debated by the European Food Safety Authority (EFSA). Strains that have an MIC of ampicillin of 2 mg/L and lack IS16/esp/hyl genes should be regarded as safe for use as feed additives in animal nutrition, despite the lack of knowledge about putative virulence marker (PVM) distribution in community Efm. We analysed the distribution of major PVM and ampicillin phenotypes in large Efm collections to investigate further the safety of strains from a public health perspective.
Introduction
Enterococcus faecium (Efm), a human and animal colonizer, is also a leading cause of hospital-acquired infections, mainly urinary tract and surgical infections, bacteraemia and endocarditis, the incidence of which continues to increase in Europe. 1 Studies of the population structure of Efm have revealed that the species is split into two major clades comprising isolates principally associated with hospitalized humans (HA) and community-based individuals (CA), respectively. 2 These groups have also been identified using different approaches and have alternatively been named clade A and clade B, epidemic hospital strains (A1) being distinguished from strains from animals and sporadic human infections (A2). 3, 4 Strains within the clade HA/clade A1 (formerly classified as CC17 by MLST), seem to be enriched in different adaptive features including metabolic capabilities, antibiotic resistance genes and traits enhancing colonization or pathogenicity in comparison with those of CA/clade B. 3, 5, 6 The putative virulence genes most thoroughly studied at the functional level include those encoding a putative glycoside hydrolase (HylEfm) and several Efm surface proteins (Fms) involved in adhesion, biofilm formation and pili assembly, namely Esp (enterococcal surface protein), Acm (adhesin of collagen from Efm), Scm (second collagen adhesin from Efm), SgrA (serine-glutamate-repeat-containing-protein A) and EcbA (Efm-collagen-binding-protein A). [6] [7] [8] [9] In addition IS16, which is thought to enhance genomic plasticity, has been found to be a putative genetic marker of hospital strains. 10 The occurrence of these and other putative virulence markers (PVM) that have recently arisen from genome sequencing projects (e.g. ptsD or orf1481 from a genomic island) and their association with infectionderived strains is lacking in comprehensive Efm collections. 11, 12 Indeed, the few gene-based studies suggesting that the enrichment of a number of Fms genes in infection-derived strains may V C The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
favour hospital adaption included low numbers of animal isolates [n " 131 in one study (20 countries ; 109 humans, 12 animals); n " 433 in another study (10 countries; 264 humans, 30 animals)]. 6, 8, 13 On the other hand, other surveillance studies related to outbreak reports or biased collections rarely include non-clinical strains. All the above-mentioned studies investigated only a few virulence markers. [14] [15] [16] Most HA/clade A1 Efm isolates are also ampicillin resistant (.90%; MIC generally .128 mg/L) while most isolates associated with CA/clade B are susceptible to this antibiotic. 3, 17, 18 Despite the available information related to the distribution of virulence traits in Efm isolates, there is a lack of evidence for a correlation between virulence profiles and an increased risk of human infection for Efm strains beyond a handful of well-known clones, and especially from the community setting. Indeed, most available information with respect to Efm PVM comes from clade A1, data from Efm in clades A2 and B remaining scarce. The need to evaluate the risk of infection and/or transmission of antibiotic resistance traits through the food chain and, more specifically, the risk of using Efm as a feed additive for animal nutrition is of utmost relevance to the European Food Safety Authority (EFSA) and currently under debate. 19 Accordingly, any Efm strain that has an MIC of ampicillin of 2 mg/L and lacks all IS16, esp and hyl genes should be regarded as safe by potentially excluding high-risk strains of clade A1. To gain insights on this topic, we assessed the distribution of an extended set of PVM in a comprehensive collection of clonally diverse Efm and correlated the results with ampicillin-resistant phenotypes. These data will be helpful to support public health efforts in the containment of human infections caused by Efm, a bacterial species particularly prone to exhibit MDR.
Materials and methods

Epidemiology and characterization of the bacterial collection
We selected a heterogeneous set of 328 Efm isolates associated with infections of hospitalized patients (C, n " 193) and non-clinical sources (NC, n " 135) for this study (Table S1 , available as Supplementary data at JAC Online). Non-clinical sources included food animals (n " 54, swine, chickens, aquaculture trout, calves), foodstuffs (n " 39, retail poultry, rainbow trout, ready-to-eat salads, cow's milk, pork), environmental waters (n " 19), healthy volunteers (n " 16), wild birds (n " 6) and ambulatory patients (n " 1). The isolates were selected from a collection of 2000 Efm strains we have recovered over the last decades in different surveillance studies [20] [21] [22] [23] [24] in order to obtain the maximum diversity in terms of origin/source, clonality and antibiotic resistance profiles. The clonal relationship of 284 isolates (representative of different sources and PVM profiles) was established by MLST, goeBURST and Bayesian Analysis Population Structure (BAPS) schemes, recently updated and representing a set of 1116 STs (http://pubmlst.org). 20, 25, 26 Ampicillin susceptibility testing was performed by Etest (0.016-256 mg/L) and broth microdilution (0.0625-256 mg/L) methods following EUCAST guidelines. 27 Cationadjusted Mueller-Hinton II agar (bioMérieux, Marcy-l'Étoile, France) was always freshly prepared and Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212 were used as controls.
Extended screening of PVM
PCR-based assays and sequencing of representative products were used to screen for the occurrence of 33 genes previously suggested as putative virulence or relevant genetic markers. They comprised: (i) IS16; (ii) hyl Efm ; (iii) ptsD; (iv) a marker of the putative genomic island mentioned previously and important in HA infections (orf1481); (v) genes coding for 24 cell-wallanchored proteins (CWAP; also known as Efm surface proteins or Fms) that include esp, sgrA, fms3, fms6, fms7, fms12, fms22, orf773, orf2109 and 15 microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) [acm; scm; ecbA; fms15; fms20-fms21 (pili gene cluster 1, PGC-1; fms21 is also known as pilA); fms14-fms17-fms13 (PGC-2); ebpAebpB-ebpC (PGC-3; ebpC is also known as pilB); fms11-fms19-fms16 (PGC-4)] encoding collagen adhesins and pili; (vi) other adhesins (fnm and sagA); and (vii) genes coding for small WxL proteins (swpA, swpB, swpC). [8] [9] [10] [11] [28] [29] [30] The acm (both the screening 1500 bp acm and the intact 2166 bp acm*), fms15, ecbA and fms21 were each tested by two sets of primers to cover false negatives obtained with primers targeting variable regions (ecbA, fms21) or potential pseudogenes (acm, fms15).
14,28 Efm Aus0004, Aus0085 and C68 strains were used as positive controls for the PCR reactions. Efm strains JH2-2 and V583, both included as negative controls, did not amplify any of the 33 PVM genes. The categorization, nomenclatures and the primers used to search for PVM are given in Table 1 . 8, 9, 14, 31 Location and transferability of specific virulence genes
The plasmid location of fms21 (or pilA), hyl and IS16 has been extensively documented 10, 32, 33 and was here assessed by hybridization of S1-digested genomic DNA using specific probes from Efm Aus0004 (pilA) and Efm C68 (IS16, hyl Efm ) as described previously. 32 The transferability of specific PVM (IS16, hyl, ptsD, orf1481, esp, sgrA, ecbA and fms21), which were more commonly identified in clinical isolates and/or previously linked to plasmids, was assessed by testing these genes in representative transconjugants (TC) that were obtained in previous studies with vancomycin (n " 32) or ampicillin (n " 9) selective plates. 17, 21 The replication initiator protein (RIP) of pLG1 was tested (PCR/hybridization) in isolates carrying fms21 on megaplasmids, as described previously. 21 
Statistical analysis
The profiles of PVM were visualized in a heatmap built with the 'pheatmap' package in 'RStudio'. The differences between groups of isolates categorized according to sources, clades and resistance phenotypes ( Table 2) in their distributions of PVM were compared using a two-tailed Fisher's exact test. Figure 1 (a) illustrates the population structure of Efm isolates (125 STs) which was split into clades A and B [A1 (47%), A2 (46%) and B (7%)] and BAPS (7 BAPS groups and 17 BAPS subgroups). The BAPS groups 2 (36%) and 3 (52%) were overrepresented in comparison with BAPS groups 1, 5, 6, 7 or 9 (1%-7%). While isolates from hospitalized patients, hospital wastewater and swine were distributed among the three clades, isolates from wild birds were found only within clades A1 and A2, poultry isolates were confined to clade A2, and the remaining isolates (from cows, trout and healthy volunteers) belonged to clades A2 and B. Nevertheless, a strong relationship between BAPS 2.1a, 3.3a1 and 3.3a2 (forming the clade A1) and clinical isolates (85%), between BAPS 2.1b and animals (64%) and between BAPS 3.2 and pigs (69%) was observed (P , 0.05). Although clinical isolates frequently belonged to clade A1 (65%), a significant percentage belonged to clade A2 (31%) and more rarely to B (4%). Other studies have also recently linked a significant number of clinical isolates to clades A2 and B, 3, 4, 20 suggesting the relevance of both endogenous and exogenous acquisition routes for infections caused by Efm. 20, 22 Distribution of E. faecium virulence markers Distribution of E. faecium virulence markers JAC Table 1 . 190 (98) 132 (98) 132 (98) 128 (98) 19 (100) 40 (100) 56 (100) 36 (95) 192 (99) 130 (97) 259 (98) 63 (98) orf2109 322 (98) 189 (98) 133 (98) 133 (99) 129 (98) 17 (90) 39 (98) 56 (100) 38 (100) 194 (100) 128 (96) 260 (98) 62 (97) swpA 323 (98) 190 (98) 133 (98) 133 (99) 129 (98) 19 (100) 39 (98) 56 (100) 38 (100) 194 (100) 129 (96) 260 (98) 63 (98) fms6 318 (97) 188 (97) 130 (96) 133 (99) 128 (98) 18 (95) 39 (98) 56 (100) 38 (100) 191 (98) 127 (95) 257 (97) 61 (95) fms3 310 (94) 186 (96) 124 (92) 131 (98) 120 (92) 17 (90) 39 (98) 54 (96) 38 (100) 190 (98) 120 (90) 251 (95) 59 (92) swpB 310 (94) 188 (97) 130 (96) 130 (97) 123 (94) 18 (95) 39 (98) 55 (98) 36 (95) 188 (97) 122 (91) 249 (94) 61 (95) fms7 308 (94) 181 (94) 127 (94) 132 (98) 120 (92) 15 (79) 39 (98) 55 (98) 38 (100) 192 (99) 116 (87) 251 (95) 57 ( (95) 56 (100) 37 (97) 193 (100) 109 (81) 256 (97) 46 (72) fms12 290 (88) 166 (86) 124 (92) 117 (87) 116 (88) 18 (95) 36 (90) 47 (84) 34 (90) 170 (88) 120 (90) 230 (87) 60 (94) swpC 285 (87) 169 (88) 116 (86) 120 (90) 110 (84) 18 (95) 37 (92) 56 (100) 27 (71) 164 (84) 121 (90) 223 (84) 62 (97) sagA 282 (86) 154 (80) 128 (95) 114 (85) 112 (86) 12 (63) 33 (82) 53 (95) 29 (76) 173 (89) 101 (75) 230 (87) 48 (75) fms21
Results and discussion
Diversity of Efm clones
JAC
278 (85) 169 (88) 109 (81) 127 (95) 100 (76) 13 (68) 37 (92) 53 (95) 37 (97) 180 ( 52 (93) 36 (95) 172 (89) 100 (75) 226 (86) 46 (72) ebpC 256 (78) 152 (79) 104 (77) 115 (86) 102 (78) 9 (47) 32 (80) 50 (89) 33 (87) 162 (84) 94 (70) 216 (82) 40 ( 47 (84) 37 (97) 168 (87) 93 (70) 221 (84) 40 ( 48 (86) 35 (92) 172 (89) 101 (75) 228 (86) 45 (70) fms22 259 (79) 164 (85) 95 (70) 116 (87) 91 (70) 17 (90) 37 (92) 42 (75) 37 (97) 170 ( 36 (64) 32 (84) 148 (76) 96 (72) 207 (78) 37 (58) acm e 231 (70) 139 (72) 92 (68) 97 (72) 79 (60) 18 (95) 28 (70) 42 (75) 27 (71) 147 (76) 84 (63) 188 (71) 43 ( (40) 9 (16) 7 (18) 37 ( (25) 28 (50) 15 (40) 74 ( 34 (61) 36 (95) 140 (72) Distribution of E. faecium virulence markers Freitas et al.
Distribution of PVM between Efm of clades A1, A2 and B demonstrates the repertoire of PVM among different Efm populations and the relevance of specific PVM as genetic markers of infection-derived strains
Strains from clade A1, independent of their source, were the more frequently enriched in PVM (often .25 genes) and all isolates associated with hospital outbreak clones dating from 1992 carried 25-32 genes (Figure 1b) . Within clade A2, a variable set of PVM genes was observed (,15 to .25 genes), even within isolates from the same source. Enriched A2 strains (.25 PVM genes) were mostly obtained from hospitals, hospital wastewater or wild birds and belonged to BAPS 2.3a, 3.1, 5 and 7. With the exception of two isolates enriched in PVM (ST108 and ST890 from a pig and a healthy volunteer), a reduced number of PVM were observed in clade B strains, independent of their source. Twenty PVM were carried by .70% of the isolates analysed, independent of their source or clade. They included surface-exposed genes [acm, scm, orf773, orf2109, fms3, fms6, fms7, fms12, fms15, fms22 and members of PGC such as PGC-1 (fms21), PGC-2 (ebpB, ebpC) and PGC-3 (fms13, fms17)], other adhesins (fnm, sagA) and all WxL genes (swpA, swpB, swpC) ( Figure 2a and Table 2 ). This remarkable common backbone corresponding to a plethora of surface proteins with variable binding specificities may help Efm colonize different hosts, contributing both to its widespread occurrence and its virulence. It is possible that some of these predominant fms genes have differential expressions in different hosts or may be non-functional (pseudogenes), but that is beyond the scope of this study.
9, 28 Moreover, gene sequencing of representative isolates showed different variants of surface proteins and pilins in clinical and non-clinical Efm (hospital variant 1 and community variant 2, respectively, as described by Qin et al.
34
) (data not shown). The other 13 genes analysed [either encoding surface-exposed molecules (esp, sgrA, ecbA, complete acm*), pili (fms11-fms19-fms16 (PGC-4), fms14, fms20 and ebpA) or other functions (IS16, hyl, ptsD, orf1481)], from now on designated major PVM, were more commonly identified in isolates from hospitalized patients (P , 0.0001), mostly within clade A1, and to a lesser extent clade A2 and/or B (Tables 2 and 3 and Figure 2a) . ptsD, IS16, sgrA and orf1481 (group I) were the most common PVM genes found among clinical Efm, and were mostly from clade A1, less frequent in clade A2 and nearly absent in clade B (P , 0.0001; Tables 2 and 3 and Figure 2a ). Among these four genes, ptsD was predominant among ampicillin-resistant Efm, both from clinical (all but four ampicillin resistant with an MIC of ampicillin of 8 mg/L; clades A1 and A2) and community (pigs, wild birds and healthy volunteers; all from clade A1) sources. Based on this observation of ptsD as a putative marker of relevant ampicillin-resistant Efm clones, we screened this gene in an additional 1077 Efm isolates from different sources and clonal backgrounds (317 ampicillin resistant and 760 ampicillin susceptible; Table S2 ). Only eight ampicillin-susceptible isolates carried ptsD (0.7%), four of which were associated with bloodstream infections, further confirming the strong positive association of ptsD with ampicillin-resistant Efm. IS16, orf1481 and sgrA were infrequent (5%-15%) but not as rare as ptsD in non-clinical ampicillin-susceptible Efm isolates (Table 2 and data not shown). This study corresponds to the first clear association of ptsD with diverse ampicillin-resistant Efm dating from 1986, and corroborates recent observations from other studies indicating the relevance of genes from phosphotransferase systems in individuals receiving b-lactam treatment. 35 On the other hand, mutations related to ampicillin resistance seem to largely affect transport of carbohydrates. 36 hyl, acm*, esp and ecbA genes (group II) were more often observed among clinical ampicillin-resistant Efm from clade A1 (P , 0.0001), although they were present at lower rates in all Efm studied, including clinical ones. esp and ecbA have been variably detected in different studies, which might depend on the clonal variability of the sample (strains of ST18 lineage were less enriched in esp and ecbA than ST17 and ST78 lineages in this collection; Table 2 ). Recent reports of local outbreaks or local collections describe high rates (.80%) of esp and ecbA in ST78 clones, 20, 37 while retrospective regional data show low rates (,30%) of these genes in clinical ST18-related clones 20 (A. R. Freitas, C. Novais and L. Peixe, unpublished data). To a lesser extent, esp, ecbA and acm* were equally distributed between clades A2 and B. In contrast to pioneer studies, the functional role of hyl has been elucidated and appears not to be essential in the pathogenesis of Efm, possibly explaining its variable and often low frequency in infection-derived strains. 38 Regarding pili (group III), the presence of the accessory fms20, fms14 and ebpA genes correlated well with the presence of complete PGC-1, PGC-2 and PGC-3, respectively. They were associated with both clinical and non-clinical Efm from different sources including foodstuffs and animals (Tables 2 and 3 and Figure 2a ), but in this case too, sequencing of representatives demonstrated different protein variants between clinical (hospital variant 1) and non-clinical Efm isolates. Moreover, the co-occurrence of the four complete PGC was significantly more abundant in clinical ampicillin-resistant Efm from clade A1 (P , 0.0001; Table 2 ). In particular, the complete PGC-2 was present in all Efm from BAPS 3.1 (clade A2), a clonal subgroup that has been associated with miscellaneous isolates including limited clonal outbreaks (e.g. ST125, ST280). 21 Its enrichment in specific pili might confer a selective advantage in different hosts. In contrast to the other PGC, both the accessory (fms11, fms19) and major (fms16) subunit pili genes of PGC-4 were strongly linked to ampicillin-resistant Efm strains. PGC-4 was identified in our work in different animal ampicillin-resistant Efm isolates from clade A2 (Figure 2a ) and, in a previous study, were observed in most ampicillin-resistant isolates from pet animals. 29 An association between specific PVM and particular types of infection could not be established.
Current criteria for 'safe Efm' (MIC of ampicillin of £2 mg/L and absence of esp, hyl and IS16) need revising Distribution of E. faecium virulence markers JAC Table 4 . Only complete PGC were considered: PGC-1 (PilA), fms21-fms20; PGC-2, fms14-fms17-fms13; PGC-3 (PilB), ebpA-ebpB-ebpC; and PGC-4, fms11-fms19-fms16.
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infections [clades: A1, n " 2; A2, n " 20; and B, n " 7; 28 bacteraemia and 1 urinary tract infection (UTI)] were identified with different PVM profiles (ptsD, sgrA, orf1481, acm* and/or PGC-1 to -4) but lacking esp, hyl and IS16 (Tables 4 and 5 Further studies are needed to clarify the pathogenic potential of different Efm hosts carrying individual or specific combinations of the PVM studied. In any case, our data clearly demonstrated that: (i) the PVM IS16, ptsD, sgrA and orf1481 were more frequent in clinical Efm and rare in community Efm, and might be considered as good markers of infection-derived Efm (group I); (ii) esp, hyl, ecbA and the complete acm were variably detected in clinical Efm, and never exclusively present in infection-derived Efm; (iii) even though more studies are necessary to better address the role of pili, our data suggest that particular variants (hospital variants in clinical Efm) might be important in infection-derived Efm [based on the fact that: (a) the protein variants of pili vary; (b) infection-derived Efm consistently carry at least one complete PGC; and (c) even infection-derived Efm expressing low levels of ampicillin resistance often exclusively carry PGC (Table 5) ]; (iv) the occurrence of PVM from group II in infection-derived Efm strains was always associated with the detection of PVM from groups I and III; and (v) the cumulative presence of most of the PVM mentioned (groups I, II and III) is of concern since most outbreak, persistent and epidemic Efm strains were associated with the co-occurrence of several genes (.7) ( Table 3) .
Not all PVM relevant to Efm pathogenicity were tested here and some are surely still unknown, but our data additionally supported the conclusion that a few genes promoting adherence to host tissues (such as PGC) and high-density colonization, which is probably enhanced in immunocompromised and/ or elderly patients by multiple and prolonged antibiotic therapies, might favour human infection. 20, 39 PVM can be horizontally transferred along with antibiotic resistance fms21 (or pilA) was located in one or two plasmids of variable size (60-280 kb) carried since 1988 by unrelated Efm and occasionally co-located with vanA, IS16 and/or hyl Efm , as observed in previous studies. 32, 33 Most fms21 (pilA) megaplasmids (.150 kb) hybridized with the RIP of pLG1 in isolates from different sources and backgrounds, which constitutes the first association of fms21 (pilA) with pLG1-like plasmids since its description. 40 IS16 was either located in the chromosome and/ or plasmids (50-220 kb), while hyl Efm was only associated with megaplasmids (.180 kb). While fms21 (pilA) was identified in most of the 41 TC tested (85%, clinical and non-clinical donors), Table 5 . 1 (4) 1 (7) 1 (25) 7 (70) 17 (81) 13 (81) 128 (91) esp 0 1 (6) 1 (6) 2 (9) 1 (3) 0 1 (7) 1 (25) 3 (30) 9 (43) 7 (44) 81 ( 1 (10) 3 (14) 3 (19) 29 (21) ptsD 0 1 (6) 1 (6) 1 (4) 1 (3) 1 (4) 4 (29) 1 (25) 5 (50) 16 (76) 11 (69) 130 ( 
(13)
1 (4) 1 (7) 1 (25) 7 (70) 18 (86) 12 (75) 125 (89) orf1481 0 2 (12)
1 (6) 1 (4) 2 (6) 0 1 (7) 1 (25) 5 (50) 16 (76) 12 (75) 128 (91) acm*
(12)
3 (18) 3 (18) 3 (14) 3 (10) 1 (4) 1 (7) 1 (25) 1 (10) 6 (29) 6 (38) 59 ( 1 (4) 4 (29) 1 (25) 3 (30) 9 (43) 5 (31) 88 (63) Complete PGC-1
(75)
8 (47) 8 (47) 11 (50) 15 (48) 9 (32) 6 (43) 3 (75) 7 (70) 15 (71) 11 (69) 101 (72) Complete PGC-2
(12)
9 (53) 10 (59) 13 (59) 8 (26) 2 (7) 0 1 (25) 5 (50) 14 (67) 11 (69) 112 (80) Complete PGC-3 0 4 (24) 7 (41) 5 (23) 3 (10) 2 (7) 1 (7) 2 (50) 5 (50) 13 (62) 12 (75) 92 (66) Complete PGC-4 0 4 (24) 4 (24) 5 (23) 8 (26) 4 (14) 2 (14) 1 (25) 8 (80) 19 (90) 13 (81) 119 (85) PGC-1 (PilA), fms21-fms20; PGC-2, fms14-fms17-fms13; PGC-3 (PilB), ebpA-ebpB-ebpC; PGC-4, fms11-fms19-fms16; PVM, putative virulence markers. Grey shading indicates groups of isolates that include at least one Efm clinical isolate involved in a human infection. Grey shading and bold formatting indicates groups of isolates that include at least one clinical isolate involved in a human infection with an MIC of ampicillin of 2 mg/L and which lacked all IS16/esp/hyl genes.
Distribution of E. faecium virulence markers JAC IS16, sgrA and hyl Efm were transferred in 24%, 20% and 5% of the cases, respectively, all corresponding to donors of clinical origin. ptsD was not identified in any TC, despite its recent finding in a large non-pLG1 hyl-carrying plasmid 41 and the descriptions of extensive transfer of sugar-related genes between clade A Efm strains, 42 suggesting its location on the chromosome, on non-mobilizable plasmids, on plasmids that were not selected in the conjugation conditions used or on other mobile genetic elements (MGEs). It is noteworthy that sgrA, which was recently associated with a transferable pbp5 ampicillin resistant platform containing genes involved in different cell functions, 17 was exclusively detected in clinical ampicillin-resistant donors (eight of nine TC). This is further supported by the data included in Table 5 showing a positive correlation for several PVM, including sgrA, and increasing ampicillin MIC values. Interestingly, within an ampicillin MIC range of 0.064-2 mg/ L (mostly non-clinical isolates) the prevalence of PVM of groups I and II (see previous section) was quite low, and the near absence of isolates enriched in PVM for the lowest MIC tested (0.064-0.125 mg/L), compared with the high frequency of PVM for an ampicillin MIC of .256 mg/L, was remarkable. The MIC of ampicillin of 2 mg/L proposed by the EFSA is indeed associated with a lower number of PVM, but does not guarantee the absence of strains with virulence genes previously highly linked to human infections caused by Efm. The association between PVM and transferable MGEs means that the safety of particular Efm clonal lineages (e.g. clade B) cannot be assumed.
Conclusions
This is the first study to assess the distribution of an extended set of virulence genes in clonally diverse Efm from disparate hosts, correlating their occurrence with ampicillin-resistant phenotypes and proposing a consensus set of relevant PVM for the tracking of infection-derived Efm clones. One limitation of our study is the biased clinical collection of isolates (mostly VRE), though it still includes a large number of animal/food isolates compared with previous studies.
Strains with higher ampicillin MIC values contained a higher number of PVM, independent of their clonal group or source, and might present a greater risk in terms of pathogenicity. PVM coding for surface (esp/sgrA/ecbA/complete acm) and pili proteins, or others enhancing colonization (hyl/ptsD/orf1481) or plasticity (IS16), were strongly associated with clinical Efm (mostly clade A1), but were also observed in clades A2/B at different rates. This study corroborates the association of particular pili variants with infection-derived Efm, stressing the need to sequence pili genes for strain risk analysis. Based on our data and in light of the current literature, we propose that ptsD, IS16, orf1481, sgrA and hospital variants of complete PGC should be considered when assessing the safety of Efm strains. The safety markers recently proposed by the EFSA as distinctive markers of safe Efm are not strict enough to avoid dissemination throughout microbial food additives of strains with the potential to cause human infections, thereby posing a risk to public health.
